When considering investing in UVC disinfection technology for your hospital or facility, it is important to look to third-party, independent research that validates the technology’s effectiveness in a real-world setting. There are more than 20 independent, third-parties studies on Tru-D and its technology, including the first-ever randomized clinical trial on

Flu isn’t a “bad cold” and can result in serious health complications, such as pneumonia, bacterial infections and can lead to hospitalization. Flu can sometimes even lead to death. Most people who get flu will recover in several days to less than two weeks, but some people will develop serious flu

In the hierarchy of scientific studies, randomized clinical trials are some of the most highly-regarded. Until 2017, there had not been a randomized control trial on UVC disinfection in the health care setting. The Benefits of Enhanced Terminal-Room Disinfection study, or BETR-D study, was the first to examine UVC disinfection

The CDC has released new information and statistics on the prevalence of health care-associated infections, or HAIs. Nationally, among acute care hospitals, there was a 1-13% statistically-significant decrease in specific HAI types between 2016 and 2017. The CDC previously reported that 1 in 25 patients will contract an HAI; however,